[1]
Lebwohl, M., Egeberg, A., Linaberry, M., Hoyt, K., Banerjee, S., Kisa, R.M. and Strober, B. 2023. Deucravacitinib in moderate to severe plaque psoriasis: liver transaminase results from the phase 3 POETYK PSO program. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s116. DOI:https://doi.org/10.25251/skin.7.supp.116.